Home Latest news Rare primary liver cancers: An EASL (European Association for the Study of the Liver) position paper

Rare primary liver cancers: An EASL (European Association for the Study of the Liver) position paper

by informer
34 views

Photo credits: pixabay.com

In recent years, owing to advances in our understanding of hepatocarcinogenesis, rare primary liver cancers (PLCs), including combined hepatocellular-cholangiocarcinoma, fibrolamellar carcinoma, and hepatic epithelioid hemangioendothelioma have garnered increased attention.

In this position paper, an international panel of experts representing oncology, hepatology, pathology, radiology, surgery, and molecular biology has summarised the available information and evidence on the pathogenesis, diagnosis, and treatment of rare PLCs.

While clinical trials of systemic treatments are underway for some rare PLCs, it is evident that more research, involving national and international collaboration, is required. Read the full document here.

Related Articles